MICHELLE VIETZ: Open Payments
NPI 1083282552 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 9 payments from 6 companies in 2025. Trend: 2023 $139 · 2024 $159 · 2025 $323
Education: $210Food & beverage: $113
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $193 |
| Astellas Pharma US Inc | 2 | $36 |
| Genentech USA, Inc. | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| Kite Pharma, Inc. | 1 | $20 |
Products named: Enhertu, Vyloy, Polivy, Zoladex, RYBREVANT, Yescarta.
Industry payments across NE — which companies pay providers there.
